he analysis of cellular blood components in what is known as a complete blood count (CBC) is one of the basic methods to detect abnormalities in haematopoiesis. Diagnostic investigations for haemato-oncological diseases involve further differentiation testing of peripheral blood or bone marrow by means of cytology, histology, immunophenotyping, cytogenetics, molecular cytogenetics and molecular genetics. Limbach Gruppe provides the medical and methodological expertise needed for targeted diagnosis, prognostic assessment and therapy monitoring.